Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,185 | 37 | 97.6% |
| Food and Beverage | $84.95 | 5 | 2.0% |
| Education | $19.68 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $4,205 | 38 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $22.70 | 1 | $0 (2021) |
| Avion Pharmaceuticals | $16.04 | 1 | $0 (2019) |
| Organon LLC | $15.90 | 1 | $0 (2021) |
| AbbVie, Inc. | $15.23 | 1 | $0 (2019) |
| TherapeuticsMD, Inc. | $15.08 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $38.60 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($22.70) |
| 2019 | $4,251 | 41 | AMAG Pharmaceuticals, Inc. ($4,205) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/07/2021 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: CONTRACEPTIVES | ||||||
| 06/15/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena, Skyla | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Women's Health | ||||||
| 11/21/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Endocrinology | ||||||
| 10/29/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $138.30 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/29/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $48.60 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/28/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $731.40 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/28/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $140.03 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/28/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $39.83 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/28/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $36.39 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/27/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $89.44 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/26/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $89.42 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/25/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $806.98 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/25/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $352.92 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/25/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $172.75 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/25/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $89.12 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/25/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $89.12 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/18/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $94.47 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/18/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $74.77 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/18/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $24.05 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/18/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $17.17 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/17/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $69.41 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/17/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $64.94 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/17/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $46.65 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/17/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $44.59 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 10/16/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $114.02 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 304 | 320 | $20,340 | $11,813 |
| 2020 | 4 | 194 | 213 | $13,470 | $7,465 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 111 | 111 | $7,110 | $4,700 | 66.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 58 | 58 | $3,190 | $2,768 | 86.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 39 | $5,995 | $2,760 | 46.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $2,530 | $1,233 | 48.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 97 | 101 | $1,515 | $351.48 | 23.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 70 | 70 | $4,200 | $3,065 | 73.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 43 | $6,450 | $2,611 | 40.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 33 | 33 | $1,815 | $1,558 | 85.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 65 | 67 | $1,005 | $232.39 | 23.1% |
About Dr. Michael Bourque, MD
Dr. Michael Bourque, MD is a Obstetrics & Gynecology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760585855.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bourque, MD has received a total of $4,290 in payments from pharmaceutical and medical device companies, with $38.60 received in 2021. These payments were reported across 43 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($4,185).
As a Medicare-enrolled provider, Bourque has provided services to 498 Medicare beneficiaries, totaling 533 services with total Medicare billing of $19,279. Data is available for 2 years (2020–2021), covering 9 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Hartford, CT
- Active Since 09/06/2006
- Last Updated 01/06/2012
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1760585855
Products in Payments
- MAKENA (Drug) $4,185
- Kyleena (Drug) $22.70
- INTRAROSA (Drug) $19.68
- Balcoltra (Drug) $16.04
- NEXPLANON (Drug) $15.90
- Orilissa (Drug) $15.23
- IMVEXXY (Drug) $15.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Hartford
Dr. Alan Fine, Md, MD
Obstetrics & Gynecology — Payments: $194,586
Dr. Adam Steinberg, Do, DO
Obstetrics & Gynecology — Payments: $138,680
Frederick Rau, Md, MD
Obstetrics & Gynecology — Payments: $137,252
Divya Gupta, Md, MD
Obstetrics & Gynecology — Payments: $85,855
Theodoros Kapetanakis, M.d, M.D
Obstetrics & Gynecology — Payments: $7,134
Elizabeth Deckers, M.d, M.D
Obstetrics & Gynecology — Payments: $5,037